Myrtle Beach pastor John-Paul "JP" Miller was arrested Nov. 6 and charged with third-degree assault and battery after a ...

Pivotal trial design can make or break a new therapy's commercial viability. This article explores how choosing the right ...

Abbott and Reckitt unit Mead Johnson are not responsible for a young boy's debilitating intestinal disease, a jury found on ...

The global pediatric clinical trial market is poised for significant growth at a CAGR of 5.9% from 2024 to 2034. The global market size is projected to reach USD 17,918.1 million in 2024. By 2034, the ...

Viking (VKTX) also presented data on the injectable version of VK2735 that is currently being tested in a Phase 2 trial. But much ... the existing drugs on the market have to be injected rather ...

Summary of Mount Sinai's New York BCI Symposium, by Synchron and Precision Neuroscience. Market Trends and forecast for brain ...

Anavex announced new data from their phase 2b/3 Alzheimer's trial, which was presented at the CTAD 2024 conference. Read why ...

The global clinical trial biorepository and archiving solution market is on track for remarkable growth, with revenues expected to soar from USD 4,877.7 million in 2024 to an estimated USD 13.7 ...

LLY’s slashed revenue and earnings guidance for 2024 were a surprise, especially given substantial raises to its outlook ...

Ocugen ( OCGN -6.48%) Q3 2024 Earnings Call Nov 08, 2024, 8:30 a.m. ET Good morning and welcome to Ocugen's third quarter 2024 financial results and business update. [Operator instructions] I will now ...